Evidence map›Paper›PMID 30357696›Full record

ReviewAdvances in experimental medicine and biology

Stem Cell and Advanced Nano Bioceramic Interactions.

Sevil Köse, Berna Kankilic, Merve Gizer, Eda Ciftci Dede, Erdal Bayramli, Petek Korkusuz, Feza Korkusuz

Erratum issuedOpen access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Core-Shell Magnetic Nanocarriers: FeInternational journal of nanomedicine · 2025
    Article
  3. Review
  4. A Novel Hydroxyapatite/Vitamin BPharmaceuticals (Basel, Switzerland) · 2023
    Article
  5. Existing and Novel Biomaterials for Bone Tissue Engineering.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Article
  8. Bioactive Materials for Soft Tissue Repair.Frontiers in bioengineering and biotechnology · 2021
    Review
  9. Review
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sevil KöseFaculty of Health Sciences, Department of Nutrition and Dietetics, Atilim University, Ankara, Turkey.
Berna KankilicHead of Certification, Directorate of Directives, Turkish Standards Institution, Ankara, Turkey.
Merve GizerDepartment of Bioengineering, Hacettepe University, Ankara, Turkey.
Eda Ciftci DedeDepartment of Bioengineering, Hacettepe University, Ankara, Turkey.
Erdal BayramliDepartment of Chemistry, Middle East Technical University, Ankara, Turkey.
Petek KorkusuzDepartment of Histology and Embryology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Feza KorkusuzDepartment of Sports Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Hacettepe University · TRAtilim University · TRMiddle East Technical University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioceramics are type of biomaterials generally used for orthopaedic applications due to their similar structure with bone. Especially regarding to their osteoinductivity and osteoconductivity, they are used as biodegradable scaffolds for bone regeneration along with mesenchymal stem cells. Since chemical properties of bioceramics are important for regeneration of tissue, physical properties are also important for cell proliferation. In this respect, several different manufacturing methods are used for manufacturing nano scale bioceramics. These nano scale bioceramics are used for regeneration of bone and cartilage both alone or with other types of biomaterials. They can also act as carrier for the delivery of drugs in musculoskeletal infections without causing any systemic toxicity.

Indexed as

Biocompatible MaterialsBone RegenerationCeramicsNanostructuresOsteogenesisCell ProliferationHumansMesenchymal Stem CellsTissue ScaffoldsBiocompatible Materialsbioceramicsbiphasic calcium phosphatehydroxyapatiteMesenchymal stem cellsnanotechnologyosteogenic differentiationosteomyelitisregenerationtricalcium phosphate

Identifiers

PMID30357696
OpenAlexW2898524626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.